AI Startup Uncovers Pricing Blind Spots Through Structured Health Assessment

The Challenge

A growing AI company offering a conversation intelligence and coaching platform had reached an inflection point in growth. While product usage and customer feedback were positive, pricing decisions had evolved incrementally without a unifying framework. Leadership suspected that pricing maturity had not kept pace with product and go-to-market evolution but lacked a structured way to diagnose the problem. Key challenges: - No objective view of overall pricing maturity - Limited visibility into pricing blind spots across teams - Difficulty connecting pricing decisions to business outcomes - Fragmented internal opinions on what needed fixing first

Our Approach

The engagement began with the Pricing Health Assessment survey, followed by a deeper diagnostic to translate insights into action. 1. PRICING HEALTH SURVEY The leadership team completed a structured survey covering five dimensions: - Strategy & Leadership - Market & Customer Insight - Offer Design & Economics - Governance & Enablement - Execution & Outcomes 2. BASELINE ASSESSMENT REPORT Delivered an initial scoring-based report highlighting strengths, gaps, and early warning signals across the five dimensions. 3. DEEP-DIVE DIAGNOSTIC Based on survey results, we conducted focused working sessions to validate assumptions, clarify root causes, and pressure-test current pricing practices. 4. BLIND SPOT IDENTIFICATION Translated survey signals into concrete issues across packaging, value metrics, discounting, and internal pricing processes. 5. PRIORITIZED ROADMAP Created a sequenced set of pricing initiatives aligned to near-term revenue impact and long-term pricing maturity.

Key Results

• Identified 10 pricing blind spots
• Established a clear pricing maturity baseline for leadership alignment
• Prioritised 4 high-impact pricing initiatives for the next 90 days
• Improved internal confidence in pricing decisions across teams